Literature DB >> 32638212

Prevalence of and risk factors for hypothyroidism after hemithyroidectomy: a systematic review and meta-analysis.

Zhe Li1, Yuxuan Qiu1, Yuan Fei1, Zhichao Xing1, Jingqiang Zhu1, Anping Su2.   

Abstract

PURPOSE: This systematic review and meta-analysis evaluated the prevalence of and risk factors for hypothyroidism following hemithyroidectomy as new evidence obtained in recent years warranted an update of previous meta-analyses.
METHODS: The PubMed, Embase, and Cochrane Library databases were searched through November 1, 2019, for articles examining the hypothyroidism prevalence and risk factors after lobectomy. The prevalence rate, risk ratio (RR), weighted mean difference (WMD) and standardized mean difference (SMD) were assessed by conducting a meta-analysis of proportions, binary variables, and continuous variables, respectively, using random-effects models.
RESULTS: Fifty-one studies showed a pooled risk of 29.9% (95% confidence interval (CI), 24.6-35.2%) for hypothyroidism following hemithyroidectomy. Risk factors for the development of postoperative hypothyroidism included the female sex (RR, 1.169; 95% CI, 1.040-1.314; P = 0.009), a higher preoperative thyrotropin (TSH) level (RR, 2.955; 95% CI, 2.399-3.640; P = 0.000), a lower preoperative FT4 level (SMD, -0.818; 95% CI, -1.623--0.013; P = 0.047), concomitant lymphocyte infiltration (RR, 1.558; 95% CI, 1.203-2.018; P = 0.001), Hashimoto's thyroiditis (HT) (RR, 1.480; 95% CI, 1.192-1.838; P = 0.000), a lighter weight of the remaining gland (WMD, -2.740; 95% CI, -3.708--1.772; P = 0.000), and a right side lobectomy (RR, 1.404; 95% CI, 1.075-1.835; P = 0.013).
CONCLUSIONS: Hypothyroidism is a significant complication after lobectomy, and appropriate and personalized surgical strategies should be designed after a careful preoperative assessment based on the estimated risk of hypothyroidism and risk factors.

Entities:  

Keywords:  Hemithyroidectomy; Hypothyroidism; Meta-analysis; Prevalence; Risk factor

Mesh:

Substances:

Year:  2020        PMID: 32638212     DOI: 10.1007/s12020-020-02410-5

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  53 in total

1.  A comparison of lobectomy and total thyroidectomy in patients with papillary thyroid microcarcinoma: a retrospective individual risk factor-matched cohort study.

Authors:  Hyemi Kwon; Min Ji Jeon; Won Gu Kim; Suyeon Park; Mijin Kim; Dong Eun Song; Tae-Yon Sung; Jong Ho Yoon; Suck Joon Hong; Tae Yong Kim; Young Kee Shong; Won Bae Kim
Journal:  Eur J Endocrinol       Date:  2017-01-15       Impact factor: 6.664

2.  Nodular recurrence and hypothyroidism following partial thyroidectomy for benign nodular thyroid disease in children and adolescents.

Authors:  M Akkari; D Schmitt; C Jeandel; I Raingeard; C Blanchet; C Cartier; R Garrel; B Guerrier; M Makeieff; M Mondain
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2014-08-08       Impact factor: 1.675

3.  Hypothyroidism Following Hemithyroidectomy: Incidence, Risk Factors, and Clinical Characteristics.

Authors:  Dongbin Ahn; Jin Ho Sohn; Jae Han Jeon
Journal:  J Clin Endocrinol Metab       Date:  2016-02-22       Impact factor: 5.958

4.  Diabetes. 1.

Authors:  A R Holder
Journal:  JAMA       Date:  1973-01-22       Impact factor: 56.272

Review 5.  Total thyroidectomy versus thyroid lobectomy in the treatment of papillary carcinoma.

Authors:  Marco Raffaelli; Serena Elisa Tempera; Luca Sessa; Celestino Pio Lombardi; Carmela De Crea; Rocco Bellantone
Journal:  Gland Surg       Date:  2020-01

6.  FACTORS INFLUENCING THE SUCCESSFUL MAINTENANCE OF EUTHYROIDISM AFTER LOBECTOMY IN PATIENTS WITH PAPILLARY THYROID MICROCARCINOMA: A SINGLE-CENTER STUDY.

Authors:  Tae Kwun Ha; Dong Wook Kim; Ha Kyoung Park; Yoo Jin Lee; Soo Jin Jung; Hye Jin Baek
Journal:  Endocr Pract       Date:  2019-06-26       Impact factor: 3.443

7.  Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association.

Authors:  Jeffrey R Garber; Rhoda H Cobin; Hossein Gharib; James V Hennessey; Irwin Klein; Jeffrey I Mechanick; Rachel Pessah-Pollack; Peter A Singer; Kenneth A Woeber
Journal:  Endocr Pract       Date:  2012 Nov-Dec       Impact factor: 3.443

8.  Lobectomy in follicular thyroid neoplasms' treatment.

Authors:  Cristiano M Antunes; António Taveira-Gomes
Journal:  Int J Surg       Date:  2013-07-14       Impact factor: 6.071

9.  Total thyroidectomy versus thyroid lobectomy for papillary thyroid cancer: Comparative analysis after propensity score matching: A multicenter study.

Authors:  Sayaka Kuba; Kosho Yamanouchi; Naomi Hayashida; Shigeto Maeda; Toshiyuki Adachi; Chika Sakimura; Fusako Kawakami; Hiroshi Yano; Megumi Matsumoto; Ryota Otsubo; Shuntaro Sato; Hikaru Fujioka; Tamotsu Kuroki; Takeshi Nagayasu; Susumu Eguchi
Journal:  Int J Surg       Date:  2016-09-24       Impact factor: 6.071

10.  Risk Factors of Post-Hemithyroidectomy Hypothyroidism.

Authors:  Alhanoof K Al-Shalhoub; Saleh Al-Dhahri
Journal:  Saudi J Med Med Sci       Date:  2016-11-16
View more
  3 in total

1.  Clinical Course of Early Postoperative Hypothyroidism Following Thyroid Lobectomy in Pediatrics.

Authors:  Julia A Baran; Andrew J Bauer; Stephen Halada; Sogol Mostoufi-Moab; Amber Isaza; Stephanie Robbins; Aime T Franco; N Scott Adzick; Tasleema Patel; Ken Kazahaya
Journal:  Thyroid       Date:  2021-12-02       Impact factor: 6.568

Review 2.  Risk of Adverse Pregnancy Outcomes in Young Women with Thyroid Cancer: A Systematic Review and Meta-Analysis.

Authors:  Shinje Moon; Ka Hee Yi; Young Joo Park
Journal:  Cancers (Basel)       Date:  2022-05-12       Impact factor: 6.575

Review 3.  Thyroid Lobectomy for Low to Intermediate Risk Differentiated Thyroid Cancer.

Authors:  Dana M Hartl; Joanne Guerlain; Ingrid Breuskin; Julien Hadoux; Eric Baudin; Abir Al Ghuzlan; Marie Terroir-Cassou-Mounat; Livia Lamartina; Sophie Leboulleux
Journal:  Cancers (Basel)       Date:  2020-11-06       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.